Pharmaceutics and novel drug delivery systems

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Pharmaceutics & novel drug delivery systems

4th International Conference on Pharmaceutical Regulatory Affairs

September 08-10, 2014 DoubleTree by Hilton Hotel Raleigh-Brownstone-University, USA

Tariq Jamshaid

Scientific Tracks Abstracts: Pharmaceut Reg Affairs

Abstract :

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Novel drug delivery is often approached via a drug?s chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration. NDDS is advanced drug delivery system which improves drug potency, control drug release to give a sustained therapeutic effect, provide greater safety; finally it is to target a drug specifically to a desired tissue. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms. Advantages of novel drug delivery system are: ? Optimum dose at the right time and right location ? Efficient use of expensive drugs, excipients and reduction in production cost ? Beneficial to patients, better therapy, improved comfort and standard of living Basic modes of novel drug delivery systems are: ? Targeted Drug Delivery System ? Controlled Drug Delivery System ? Modulated Drug Delivery System Factors affecting the design of controlled release products are: ? Physicochemical properties of a drug ? Route of administration ? Acute/Chronic therapy ? Target sites ? The Patient ? The disease state/level

Biography :

Tariq Jamshaid has 11 years diversified work experience of Quality Control, Manufacturing Processes, Pharmaceutical Product Design & Development, Process Optimization, Laboratory Management, Drug Registration Processes, GMP Requirements, Drugs Laws, Statistical Methodology, Manufacturing Process Validation, Cleaning Validation, ISO 9001:2008 with strong scientific, analytical, statistical, planning, managerial and training skills. Currently, he is working as a Sr. Manager Production & Development for Surge Laboratories Pvt. Ltd., Pakistan.

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

arrow_upward arrow_upward